MOBILE   |  REGISTER   |   LOGIN   |   HELP
HOME  |  ABOUT US  |  BLOGGERS  |  BLOGS  |  MESSAGES  |  VIDEO  |  QUIZZES  |  LIBRARY  |  WEBINARS
A Gated Community for Oncology Nurses and
Cancer Care Teams | More Info
Breast   |   Prostate   |   Lung   |   Hematology   |   Skin   |   Gastrointestinal   |   Genitourinary   |   Head / Neck   |   Brain   |   Gynecological   |   Sarcoma   |   Thyroid
Career  |  Exercise  |  Nutrition  |  Recipes  |  Survivorship  |  Symptom Management  |  Emergencies  |  Side Effects  |  Pediatrics  |  Complementary Therapies
Hematologic cancers
most recent users' messages
Blog Roll
Deborah A. Boyle

Deborah A. Boyle
Living On After Transplant
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
8/1/2017  1
Numerous contemporary advances within the specialty of hematopoietic stem cell transplantation (HSCT) are responsible for improved survival rates and the expanded use of this ...

Most recent post: CMG... Login to View
Lori Smith

Lori Smith
Methotrexate Suspension Approved for Pediatric ALL Patients
Lori Smith, BSN, MSN, CRNP
5/16/2017  0
Xatmep (methotrexate), the first and only oral methotrexate solution, has gained US Food and Drug Administration (FDA) approval in the treatment of acute lymphoblastic leukemia ...

Marijke Vroomen Durning

Marijke Vroomen Durning
Marital Status, Neighborhood Play Role in Leukemia Survival
Marijke Vroomen Durning, RN
5/4/2017  0
Marital status, where you live, and if you have health insurance may play a role in survival following a diagnosis of acute myeloid leukemia (AML), say researchers from the ...

Lori Smith

Lori Smith
FDA Warns of Breast Implant-Associated Anaplastic Large Cell Lymphoma
Lori Smith, BSN, MSN, CRNP
4/24/2017  0
The possibility of an association between breast implants and anaplastic large cell lymphoma-a rare type of non-Hodgkin lymphoma-was first recognized by the US Food and Drug ...

Deborah A. Boyle

Deborah A. Boyle
Myelodysplastic Syndrome in the Elderly
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
2/21/2017  0
Myelodysplastic syndrome (MDS) is primarily a hematological malignancy of aging. Eighty percent of cases are diagnosed in adults > age 70 who experience considerable symptom burden ...

Deborah A. Boyle

Deborah A. Boyle
Relentless Fatigue
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/26/2017  1
Of all the potential toxicities of cancer therapy, fatigue is the one side effect all patients can expect to encounter. It most recently has been the focus of increasing ...

Most recent post: CMG... Login to View
Deborah A. Boyle

Deborah A. Boyle
Adherence to Oral Cancer Drugs: The Key to Optimum Treatment Outcomes
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
1/18/2017  0
I remember more than 2 decades ago having lunch with a radiation oncologist who specialized in breast cancer therapy. In this early era of prophylactic tamoxifen therapy she said to ...

Deborah A. Boyle

Deborah A. Boyle
The Good News/Bad News Hodgkin Lymphoma Chronicle
Deborah A. Boyle, RN, MSN, AOCNS, FAAN
11/29/2016  0
Hodgkin lymphoma accounts for approximately 16% of all malignancies in adolescents and young adults (between ages 15 and 39 years).1, 2 Its 5-year survival expectations currently ...

Carole McCue

Carole McCue
New Safety Guidelines for Vincristine Administration
Carole McCue, RN, MS, CNE
11/25/2016  0
Vincristine is a chemotherapeutic agent, administered intravenously (IV) to patients with blood cancers such as leukemia or lymphoma. It is highly effective in blocking cancer by ...

Webinar Series
Tuesday, October 29, 2013 12:00 PM EDT
Archived

Presented by Ellen T. Matloff, MS, CGC , this webinar will highlight:

  • How to determine which patients require genetic counseling
  • How to help prepare your patients for the genetic counseling process
  • Testing options that are now available
  • How you can utilize this data in managing your patients and their family members

Participants will also be able to ask questions during a live question and answer period with speaker Ellen T. Matloff, MS, CGC .

Wednesday, August 28, 2013 12:00 PM EDT
Wednesday, June 26, 2013 12:00 PM EDT
Wednesday, April 10, 2013 12:00 PM EDT
Readerboards
Have a question or topic but don't want to write a blog? Post it on our readerboards and get feedback from the community!
Patriotacp on Enhance your Business through Excellent Website Promotion
karatx16 on Enhance your Business through Excellent Website Promotion
karatx16 on Enhance your Business through Excellent Website Promotion
FDA Approves Onivyde for Advanced Pancreatic Cancer
Marijke Vroomen Durning, RN,
10/27/2015  3
On October 22, 2015, the US Food and Drug Administration (FDA) approved Onivyde (irinotecan liposome injection, Merrimack Pharmaceuticals, Inc.), in combination with fluorouracil ...
Like Us on Facebook
on Twitter
TheONC Twitter Feed
TheONC.org